CASC3 and B-cell chronic lymphocytic leukemia: These disappointing results may well be related to the fact that BTZ and other PIs (e.g., MG- 132 and epoxomicin) also induce Mcl-1 accumulation, notably in CLL cells: this would decrease the PIs’ apoptotic response and thus therapeutic efficacy [206].